Factors associated with medication adherence among psychiatric outpatients at substance abuse risk.

Stephen Magura, Andrew Rosenblum, Chunki Fong
{"title":"Factors associated with medication adherence among psychiatric outpatients at substance abuse risk.","authors":"Stephen Magura,&nbsp;Andrew Rosenblum,&nbsp;Chunki Fong","doi":"10.2174/1874941001104010058","DOIUrl":null,"url":null,"abstract":"<p><p>Substance misuse is usually associated with poorer psychiatric medication adherence among psychiatric patients. Identifying predictors of medication adherence among patients with dual psychiatric and substance misuse problems is important because poor adherence is associated with relapse and re-hospitalization. The subjects were patients newly admitted to a psychiatric outpatient program who were prescribed psychiatric medication from different providers during the six months prior to admission; all also had substance misuse histories (N=131). Confidential research interviews were conducted that included a modified Medication Adherence Rating Scale (MARS) and drug toxicologies. Age (mean): 39 y; male 61%; Black 41%; Hispanic 38%; White 21%; completed high school/GED 41%; DSM-IV diagnoses: major depression 26%, schizoaffective 21%, bipolar 16%, schizophrenia 13%, other 24%; positive drug toxiology 55%. Potentially malleable factors correlated with lower adherence were: lower friends' support for drug/alcohol abstinence, more recovery-promoting behaviors, lower satisfaction with medication, more medication side effects, lower self-efficacy for drug avoidance, and lower social support for recovery. In multivariate regression analysis, only the last three factors remained as significant predictors of adherence. Low adherence is not attributable to simply forgetting to take medication. Strengthening adherence should also include better education about side effects and the importance of adherence to sustain the benefits of medication. Psychiatrists and other medical providers should also be encouraged to address patients' adherence strategies, since the time devoted to addressing that during treatment may prevent serious adverse events such as relapse to substance abuse, treatment drop-out and re-hospitalization.</p>","PeriodicalId":89289,"journal":{"name":"The open addiction journal","volume":"4 ","pages":"58-64"},"PeriodicalIF":0.0000,"publicationDate":"2011-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874941001104010058","citationCount":"51","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The open addiction journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874941001104010058","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 51

Abstract

Substance misuse is usually associated with poorer psychiatric medication adherence among psychiatric patients. Identifying predictors of medication adherence among patients with dual psychiatric and substance misuse problems is important because poor adherence is associated with relapse and re-hospitalization. The subjects were patients newly admitted to a psychiatric outpatient program who were prescribed psychiatric medication from different providers during the six months prior to admission; all also had substance misuse histories (N=131). Confidential research interviews were conducted that included a modified Medication Adherence Rating Scale (MARS) and drug toxicologies. Age (mean): 39 y; male 61%; Black 41%; Hispanic 38%; White 21%; completed high school/GED 41%; DSM-IV diagnoses: major depression 26%, schizoaffective 21%, bipolar 16%, schizophrenia 13%, other 24%; positive drug toxiology 55%. Potentially malleable factors correlated with lower adherence were: lower friends' support for drug/alcohol abstinence, more recovery-promoting behaviors, lower satisfaction with medication, more medication side effects, lower self-efficacy for drug avoidance, and lower social support for recovery. In multivariate regression analysis, only the last three factors remained as significant predictors of adherence. Low adherence is not attributable to simply forgetting to take medication. Strengthening adherence should also include better education about side effects and the importance of adherence to sustain the benefits of medication. Psychiatrists and other medical providers should also be encouraged to address patients' adherence strategies, since the time devoted to addressing that during treatment may prevent serious adverse events such as relapse to substance abuse, treatment drop-out and re-hospitalization.

精神科门诊病人药物滥用风险与药物依从性相关的因素。
药物滥用通常与精神病患者较差的精神药物依从性有关。确定双重精神和药物滥用问题患者药物依从性的预测因素很重要,因为依从性差与复发和再次住院有关。研究对象是新近进入精神科门诊项目的患者,这些患者在入院前6个月内从不同的医生那里获得了精神科药物;所有患者均有药物滥用史(N=131)。进行了保密的研究访谈,包括修改的药物依从性评定量表(MARS)和药物毒理学。平均年龄:39岁;男性61%;黑色的41%;拉美裔38%;白色的21%;高中毕业/GED 41%;DSM-IV诊断:重度抑郁症26%,分裂情感性21%,双相情感障碍16%,精神分裂症13%,其他24%;药物毒理学阳性55%。与较低依从性相关的潜在可塑因素是:朋友对药物/酒精戒断的支持程度较低,促进康复的行为较多,对药物的满意度较低,药物副作用较多,药物避免的自我效能较低,以及对康复的社会支持较低。在多变量回归分析中,只有最后三个因素仍然是依从性的重要预测因素。低依从性不能简单地归因于忘记服药。加强依从性还应包括更好地教育副作用和坚持服药以维持药物益处的重要性。还应鼓励精神科医生和其他医疗提供者处理病人的坚持战略,因为在治疗期间专门处理这一问题的时间可以防止严重的不良事件,如再次滥用药物、退出治疗和再次住院。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信